8-K
Current Report
Fulcrum Therapeutics, Inc. Filed Acc 0000950170-24-058187
Material agreement · Results of operations
- Item 1.01 Entry into a material definitive agreement
- Item 2.02 Results of operations and financial condition
From the SEC's structured data for this filing
Loading fulc-20240511.htm…